8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed Mar 24, 2026 · 3mo ago · Accession 0001104659-26-033839
Plain English
TELA Bio, Inc. announced its fourth quarter and full year 2025 financial results, including revenue of "$20.9 million" for the quarter and "$80.3 million" for the year, and also disclosed the closing of a credit facility for up to "$70.0 million" from Perceptive Advisors.
Filing details
- Company
- TELA Bio, Inc.
- Ticker
- TELA
- CIK
- 1561921
- Form type
- 8-K
- Filing date
- Mar 24, 2026
- Report date
- Mar 24, 2026
- Document
- tm269387d1_8k.htm
- Size
- 4.8 MB